Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127844161 | 12784416 | 1 | I | 20160923 | 20160927 | 20160927 | EXP | US-009507513-1609USA012118 | MERCK | GILL D. MONTELUKAST-INDUCED ANGIOEDEMA. AMERICAN JOURNAL OF THERAPEUTICS. 2016 | 52.00 | YR | M | Y | 0.00000 | 20160927 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127844161 | 12784416 | 1 | PS | MONTELUKAST SODIUM. | MONTELUKAST SODIUM | 1 | UNK | Y | 20829 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127844161 | 12784416 | 1 | Hypersensitivity |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127844161 | 12784416 | HO |
| 127844161 | 12784416 | LT |
| 127844161 | 12784416 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127844161 | 12784416 | Angioedema | |
| 127844161 | 12784416 | Dysphagia | |
| 127844161 | 12784416 | Dyspnoea | |
| 127844161 | 12784416 | Feeling abnormal | |
| 127844161 | 12784416 | Respiratory distress | |
| 127844161 | 12784416 | Wheezing |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |